Status:
COMPLETED
Intensive Prevention Program After Myocardial Infarction
Lead Sponsor:
Herzzentrum Bremen
Collaborating Sponsors:
Oldenburger Forschungs- und Entwicklungsinstitut für Informatik (OFFIS).
University of Luebeck
Conditions:
Myocardial Infarction
Prevention Harmful Effects
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
It is unknown, if a modern prevention program, including intense nurse-coordinated education sessions, regular telephone contacts and a telephone hotline for 12 months, significantly reduces cardiovas...
Eligibility Criteria
Inclusion
- Hospitalisation due to myocardial infarction (ST-elevation or non-ST-elevation myocardial infarction)
Exclusion
- i) Hemodynamically significant valvular heart disease (\> NYHA class II) or inborn cardiac malformations.
- ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis.
- iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major non-cardiac condition that would adversely effect survival during the duration of the study.
- v) Patients unlikely to comply to the study treatment and the follow-up visits. vi) Pregnancy (all pre-menopausal females should have a negative serum pregnancy test).
- vii) Inability of cooperation with the protocol, including longterm follow-up. viii) Patient refusal or inability to give informed consent. ix) Refusal of the patient's physician regarding trial participation of the patient.
- x) Chronic drug or alcohol abuse.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01896765
Start Date
October 1 2013
End Date
May 1 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herzzentrum Bremen
Bremen, Germany, 28277